In the meantime, Gabelli & Co upgraded its Iterum Therapeutics Plc [ITRM] rating to a Hold from a a Sell in a research note published recently. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who increased its forecast for the stock in mid March from “a Neutral” to “a Buy”. RBC Capital Mkts also remained covering ITRM and has decreased its forecast on June 02, 2020 with a “Sector perform” recommendation from previously “an Outperform” rating. Gabelli & Co revised its rating on January 21, 2020. It rated ITRM as “a Sell” which previously was an “a Buy”.
Price Performance Review of ITRM
On Tuesday, Iterum Therapeutics Plc [NASDAQ:ITRM] saw its stock fall -15.87% to $1.06. Over the last five days, the stock has lost -4.50%. Iterum Therapeutics Plc shares have fallen nearly -40.11% since the year began. Nevertheless, the stocks have fallen -31.61% over the past one year. While a 52-week high of $3.02 was reached on 01/06/25, a 52-week low of $0.81 was recorded on 04/21/25. SMA at 50 days reached $1.2927, while 200 days put it at $1.3933.
Levels Of Support And Resistance For ITRM Stock
The 24-hour chart illustrates a support level at 1.0200, which if violated will result in even more drops to 0.9800. On the upside, there is a resistance level at 1.1000. A further resistance level may holdings at 1.1400. The Relative Strength Index (RSI) on the 14-day chart is 40.47, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.0419, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.80%. Stochastics %K at 44.72% indicates the stock is a holding.
How much short interest is there in Iterum Therapeutics Plc?
A steep rise in short interest was recorded in Iterum Therapeutics Plc stocks on 2025-04-15, dropping by -0.29 million shares to a total of 1.24 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-14 was 1.53 million shares. There was a decline of -23.51%, which implies that there is a negative sentiment for the stock.
